Clinical trial
Clinical Efficacy and Safety of Radical Nephroureterectomy With Versus Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma: A Multicenter, Prospective, Randomized Controlled Clinical Trial
NCT07321210 is registered in ClinicalTrials.gov with Tianjin Medical University Second Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy and Safety of Radical Nephroureterectomy With Versus Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma: A Multicenter, Prospective, Randomized Controlled Clinical Trial
- Lead sponsor
- Tianjin Medical University Second Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 1, 2025
- Completion date
- August 30, 2032
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lymph node dissection, upper tract urothelial carcinoma